Search this website. You can use fund codes to locate specific funds
Sector lead: Pharmaceuticals & Healthcare
Kimberley Lewis is focusses on engagements with companies in the SDG Engagement Equity Fund, and also covers North America and pharmaceuticals pursuant to the EOS Engagement Plan. Prior to joining EOS, Kimberley was a consultant to foundations and venture capital firms on impact investing in emerging markets. Kimberley led the global corporate responsibility/social investment team at Pfizer Inc, where she was responsible for the strategy and implementation of the company’s ex-US corporate responsibility work. She designed and led the Pfizer foundation programme, including its work in social finance and global health. Prior to this, she led the emerging markets policy work at AstraZeneca. In addition, Kimberley has held roles in philanthropy, law and politics in both the US and UK. Kimberley is a US-qualified attorney, with a BA and JD from the University of Virginia; she also has an MA from London Business School, where she was a Sloan Fellow.
Why do we engage on the SDGs, when these are policy goals and not always directly applicable to companies? Our view is that the long-term success of business is inextricably linked to that of the goals.
Many delegates used Global Goals Week to call for better corporate reporting in relation to the UN Sustainable Development Goals (SDGs) and greater collaboration between stakeholders. But, as the lack of standardised data on SDG alignment poses a challenge to investors, we explain how our engagement efforts can inform investment decisions.